Pancreatic cancer surgeon who has directed the University of Colorado Cancer Center, the state's NCI-designated comprehensive cancer centre, since 2018.
Richard Schulick is Director of the University of Colorado Cancer Center on the CU Anschutz Medical Campus and Chair of the Department of Surgery at the University of Colorado School of Medicine. A surgical oncologist specialising in pancreatic and hepatobiliary cancers, his research addresses pancreatic cancer immunotherapy and surgical outcomes. He has led the centre since June 2018.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist, pancreatic cancer, surgical oncology.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist, surgical oncology.
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist, pancreatic cancer.
Shares Biliary tract cancer (cholangiocarcinoma) and the tags leadership, clinician-scientist, surgical oncology.
Shares the tags leadership, clinician-scientist, surgical oncology.
Shares the tags leadership, clinician-scientist, surgical oncology.
Shares the tags leadership, clinician-scientist, surgical oncology.
Shares the tags leadership, clinician-scientist, surgical oncology.